Tampucci, S.; Monti, D.; Burgalassi, S.; Terreni, E.; Zucchetti, E.; Baldacci, F.; Chetoni, P.
Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment. Pharmaceutics 2018, 10, 137.
https://doi.org/10.3390/pharmaceutics10030137
AMA Style
Tampucci S, Monti D, Burgalassi S, Terreni E, Zucchetti E, Baldacci F, Chetoni P.
Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment. Pharmaceutics. 2018; 10(3):137.
https://doi.org/10.3390/pharmaceutics10030137
Chicago/Turabian Style
Tampucci, Silvia, Daniela Monti, Susi Burgalassi, Eleonora Terreni, Erica Zucchetti, Filippo Baldacci, and Patrizia Chetoni.
2018. "Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment" Pharmaceutics 10, no. 3: 137.
https://doi.org/10.3390/pharmaceutics10030137
APA Style
Tampucci, S., Monti, D., Burgalassi, S., Terreni, E., Zucchetti, E., Baldacci, F., & Chetoni, P.
(2018). Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment. Pharmaceutics, 10(3), 137.
https://doi.org/10.3390/pharmaceutics10030137